Sacubitril–valsartan in heart failure and multimorbidity patients

AIMS: The poor control of symptoms in patients with advanced heart failure with reduced ejection function (HFrEF) can limit the functionality of patients. Sacubitril–valsartan, compared with enalapril, has been shown to reduce mortality and hospitalization, and nowadays, there is still little eviden...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodil Fraile, Raquel, Malafarina, Vincenzo, Tiberio López, Gregorio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165940/
https://www.ncbi.nlm.nih.gov/pubmed/30039930
http://dx.doi.org/10.1002/ehf2.12338

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165940/
https://www.ncbi.nlm.nih.gov/pubmed/30039930
http://dx.doi.org/10.1002/ehf2.12338

Ejemplares similares